Das Liza, Dutta Pinaki
Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.
J Clin Endocrinol Metab. 2023 May 17;108(6):1488-1504. doi: 10.1210/clinem/dgac747.
Hypopituitarism, which refers to insufficiency of one or more hormones of the pituitary, can be due to myriad causes. The clinical and radiological spectrum of the condition is heterogeneous, based on the patient's age, gender, clinical setting, and/or other past medical history. Hypopituitarism includes central hypocortisolism, hypothyroidism, hypogonadism, and growth hormone deficiency. Both hypo- and hyperprolactinemia can be associated with hypopituitarism, with low prolactin signifying more extensive pituitary damage. Posterior pituitary insufficiency (arginine vasopressin deficiency) occurs either in isolation or with anterior pituitary hormone deficiency. Clinical symptomatology of hypopituitarism is usually nonspecific and insidious in onset and progression. Overall, the most common cause of hypopituitarism is a pituitary adenoma and/or its management (surgery, radiotherapy, pharmacotherapy, or a combination of these). However, it is this subset of patients which is more likely to be identified and managed in a timely manner, possibly alleviating the premature mortality associated with hypopituitarism. What is more challenging is the recognition of hypopituitarism in less common settings, which may be either due to direct involvement of the pituitary (infection, traumatic brain injury, or infiltrative causes) or indirectly as a consequence of the primary process (thalassemia, vasculotoxic snakebite, subarachnoid hemorrhage). These entities are often under-recognized, and increased awareness can help in greater recognition of the burden. Further, pituitary insufficiency in most of these settings is dynamic and may progress, or rarely, show recovery of function. This renders complexity to the problem, but makes it even more imperative to suspect, screen, and appropriately manage patients with less common causes of hypopituitarism.
垂体功能减退是指垂体一种或多种激素分泌不足,其病因众多。基于患者的年龄、性别、临床情况和/或其他既往病史,该病症的临床和影像学表现具有异质性。垂体功能减退包括中枢性肾上腺皮质功能减退、甲状腺功能减退、性腺功能减退和生长激素缺乏。高催乳素血症和低催乳素血症都可能与垂体功能减退有关,低催乳素血症意味着垂体损伤更为广泛。垂体后叶功能减退(精氨酸血管加压素缺乏)可单独出现,也可与垂体前叶激素缺乏同时出现。垂体功能减退的临床症状通常不具有特异性,起病和进展隐匿。总体而言,垂体功能减退最常见的原因是垂体腺瘤及其治疗(手术、放疗、药物治疗或这些方法的联合使用)。然而,正是这部分患者更有可能得到及时的诊断和治疗,这可能会降低与垂体功能减退相关的过早死亡率。更具挑战性的是在不太常见的情况下识别垂体功能减退,这可能是由于垂体直接受累(感染、创伤性脑损伤或浸润性病因),或作为原发疾病的间接后果(地中海贫血、血管毒性蛇咬伤、蛛网膜下腔出血)。这些情况往往未得到充分认识,提高认识有助于更全面地认识其负担。此外,在大多数这些情况下,垂体功能减退是动态的,可能会进展,或很少出现功能恢复。这使得问题变得复杂,但更迫切需要怀疑、筛查并适当治疗由不太常见病因导致垂体功能减退的患者。